A simplified and reliable HPV testing of archival Papanicolaou-stained cervical smears: Application to cervical smears from cancer patients starting with cytologically normal smears

British Journal of Cancer

Volumn 82, Issue 8, 2000, Pages 1421-1426

  Jacobs, M V ^a   Zielinski, D ^a   Meijer, C J L M ^a   Pol, R P ^a   Voorhorst, F J ^b   De Schipper, F A ^c   Runsink, A P ^d   Snijders, P J F ^a   Walboomers, J M M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c Ziekenhuis Walcheren   (Netherlands)

^d District Laboratory Zeeland   (Netherlands)

Author keywords

Archival Pap smears; HPV; PCR

Indexed keywords

BETA GLOBIN; DNA; GUANIDINE DERIVATIVE; PROTEINASE K; VIRUS DNA;

ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; DNA DETERMINATION; GLOBIN GENE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS TYPING; WART VIRUS;

EID: 0034102764     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.1128     Document Type: Article

References (21)

1. de Roda Husman AM, Snijders PJF, Stel H, van den Brule AJC, Meijer CJLM and Walboomers JMM (1995) Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction. Br J Cancer 72: 412-417
2. Fleiss JL (1981) Statistical Methods for Rates and Proportions. John Wiley: New York
3. Gall K, Pavicic D, Pavelic J, Audy-Jurkovic S and Pavelic K (1993) PCR amplification of DNA from stained cytological smears. J Clin Pathol 46: 378-379
4. Ho GY, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, Basu J, Tachezy R, Lewis R and Romney S (1995) Peristent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 87: 1365-1371
5. IARC (1986) Working Group on Evaluation of Cervical Cancer Screening Programmes. Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. Br Med J 293: 659-664
6. IARC (1995) Monographs on the Evaluation of Carcinogenic Risks to Humans. Human Papillomaviruses, Vol. 64, Human Papillomaviruses. International Agency for Research on Cancer: Lyon
7. Jacobs MV, Snijders PJF, van den Brule AJC, Helmerhorst ThJM, Meijer CJLM and Walboomers JMM (1997) A general primer GP5+/6+ mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 35: 791-795
8. Jacobs MV, Walboomers JMM, van Beek J, Voorhorst FJ, Meijer CJLM, van den Brule AJC, Helmerhorst ThJM and Snijders PJF (1999) A quantitative polymerase chain reaction-enzyme immunoassay for accurate measurements of human papillomavirus type 16 DNA levels in cervical scrapings. Br J Cancer 81: 114-122
9. Koss LG (1989) The papanicolauou test for cervical cancer detection. A triumph and a tragedy. JAMA 261: 737-743
10. Meijer CJLM, Rozendaal L, van der Linden JC, Helmerhorst ThJM, Voorhorst FJ and Walboomers JMM (1998) Human papillomavirus typing or testing in gynaepathology. Has the time come? Histopathology 33: 83-86
11. Nobbenhuis MAE, Walboomers JMM, Helmerhorst ThJM, Rozendaal L, Remmink AJ, Risse EKJ, van der Linden HC, Voorhorst FJ, Kenemans P and Meijer CJLM (1999) Relation of human papillomavirus status to cervical lesions and consequences for cervical cancer screening: a prospective study. Lancet 354: 20-25
12. Ootmarssen GH van, Habbema JDF and Ballegooijen M van (1992) Predicting mortality from cervical cancer negative smear test results. Br Med J 305: 449-153
13. Poljak M, Barlie J, Seme K, Avsic-Zupanc T and Zore A (1995) Isolation of DNA from archival Papanicolaou stained cytological smears using a simple salting-out procedure. J Clin Pathol Mol Pathol 48: M55-M56
14. Puranen M, Saarikski S, Syrjanen K and Syrjanen S (1996) Polymerase chain reaction amplification of human papillomavirus DNA from archival Papanicolaou-stained cervical smears. ACTA Cytol 40: 391-395
15. Remmink AJ, Walboomers JMM, Helmerhorst ThJM, Voorhorst FJ, Rozendaal L, Risse EKJ, Meijer CJLM and Kenemans P (1995) The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 61: 306-311
16. Richart RM and Barron BA (1981) Screening strategies for cervical cancer and cervical intraepithelial neoplasia. Cancer 25: 543-549
17. Sepp R, Szabo I, Uda H and Sakamoto H (1994) Rapid techniques for DNA extraction from routinely processed archival tissue for use in PCR. J Clin Pathol 47: 318-323
18. Walboomers JMM, de Roda Husman AM, Snijders PJF, Stel HV, Risse EKJ, Helmerhorst ThJ, Voorhorst FJ and Meijer CJLM (1995) Human papillomavirus in false-negative smears: implications for screening for cervical cancer. J Clin Pathol 48: 498-503
19. Walboomers JMM, Snijders PJF and de Roda Husman (1996) Reply to the letter from Poljak et al. Br J Cancer 74: 1509
20. Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJF, Peto J, Meijer CJLM and Muñoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19
21. zur Hausen H (1994) Molecular pathogenesis of cancer of the uterine cervix and its causation by specific human papillomavirus types. In: Human Pathogenic Papillomaviruses, zur Hausen H (ed), pp. 131-156. Springer-Verlag: Berlin